Driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

27
May

27. May 2025 — Register here

European Healthcare & Life Sciences Investor Symposium

EUCOPE will participate in the Paris edition of the European Healthcare & Life Sciences Investor Symposium |Weathering the Storm: Strategies for Success in a Turbulent Global Healthcare & Life Sciences Market, which provides a series of events to be held in London and Frankfurt. Topics… read more

Our Events Section

News & Updates

EUCOPE Member Spotlight: Q&A with Muriel O’Byrne Senior Vice President and Head of International Regulatory Affairs and the European Business Office at Regeneron

Every month, EUCOPE spotlights a member company and its great work in advancing the life sciences industry and driving innovation to serve patients better. In April, we spoke with Dr. Muriel O’Byrne, Senior Vice President and Head of International Regulatory Affairs and the European Business… read more

Joint EUCOPE – IFPMA statement to support the adoption of the WHA Resolution on Rare Diseases

    16 April 2025, Geneva –  The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the innovative pharmaceutical industry worldwide, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing small and mid-sized innovative health technology companies in Europe, welcome and echo the Call… read more

EUCOPE Member Spotlight: Q&A with Corinne Schmitz – Chairman, Founder & CEO at Azurbio Pharma

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In April, we spoke with Corinne Schmitz Chairman, Founder & CEO at Azurbio Pharma. Corinne Schmitz is an accomplished… read more

EUCOPE statement on the European Commission’s Strategic Dialogue with the pharmaceutical sector and the potential of tariffs

Brussels, 8 April, 2025 – This morning, EUCOPE’s Secretary General, Dr Alexander Natz, joined the European Commission’s Strategic Dialogue with the pharmaceutical sector. We thank Commission President von der Leyen for convening this meeting as an important opportunity to share the perspective of the innovative… read more

Health Stakeholders advocate for enhanced collaboration in European Health Data Space (EHDS) Implementation

Brussels, 10 March – A coalition of 39 leading representatives from the European health community has published a joint statement welcoming the publication of the European Health Data Space (EHDS) regulation in the EU’s Official Journal. The group underscores the need to promptly establish an… read more

EUCOPE’s Sounds of Science Podcast – Episode #20 Tackling Medicine Shortages: The Role of EU Policies

Sounds of Science – episode 20 Tackling Medicine Shortages: the role of EU Policies Medicine shortages are a growing challenge across Europe, impacting patients, healthcare systems, and companies alike. But how is the EU tackling this issue? What role do EU policies and the upcoming… read more

EUCOPE Member Spotlight: Q&A with Sarah Boyce, President and Chief Executive Officer at Avidity Biosciences

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Sarah Boyce, President and Chief Executive Officer at Avidity Biosciences. Tell us about your… read more

EUCOPE’s Sounds of Science Podcast – Episode #19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions

EUCOPE’s Sounds of Science Podcast – Episode 19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions In this episode of Sounds of Science, we invited our members, Toon Digneffe and Enrico Piccinini, to discuss with Alexander Natz how the EU’s competitiveness strategies may… read more

EUCOPE Member Spotlight: Q&A with Antoine Bernasconi, Executive VP, Chief Commercial Officer Europe & International at SERB Pharmaceuticals

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In January, we spoke with Antoine Bernasconi, Executive VP, Chief Commercial Officer Europe & International at SERB Phamaceuticals. Tell… read more

EUCOPE Member Spotlight: Q&A with Catherine Owen Adams, CEO of Acadia Pharmaceuticals

Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the December edition, we spoke with Catherine Owen Adams, CEO of Acadia Pharmaceuticals. Tell us about your organization and… read more

... or browse news by Tag

Patients Rare Disease Medicines Regulatory innovation Health Access Members Research COVID19 Events Commission OMP podcast ATMPs HTA Medical Devices EMA Digital IVDR pharma EU Health biotech Job Posting European Commission Brexit MDR AdvancedDxs Life Science genomics HERA EHDS European Parliament Supply PharmaPackage SoHO Regulation data act competitiveness Safety GDPR MEDTECH clinical trial hematology cell therapies Safety Features

Our News Section

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership